AVTOZMA

Celltrion, Inc.

Application Filed: 2023-03-06
Trademark Application Details
Trademark Logo AVTOZMA
630
Live/Pending
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Research OneLook Acronym Finder
Serial Number79366724
Mark Drawing Code4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form

Timeline

2023-03-06Application Filed
2023-04-06Location: INITIAL REVIEW/SERIALIZATION BRANCH(MAILROOM)
2023-04-06Status: Live/Pending
2023-04-10Transaction Date

Trademark Applicants & Owners

Owner: CELLTRION, INC.
Address23, Academy-ro, Yeonsu-gu Incheon 22014 KR
Legal Entity TypeCorporation
Legal Entity State KR

Documents

Click the blue "Refresh" button to load certificates, specimines, application, and other documents.

Attorney of Record

KAI International IP Law Firm
4F, 19, Nonhyeon-ro 87-gil,; Gangnam-gu
Seoul 06236

REPUBLIC OF KOREA

Good, Services, and Codes

International Codes:5
U.S. Codes:005,006,018,044,046,051,052
Type CodeType
GS0051Pharmaceutical preparations; pharmaceuticals; drugs for medical purposes; preparations for the treatment of arthritis; pharmaceutical preparations for suppressing cytokine; preparations for the treatment of arteritis; pharmaceutical preparations for the treatment of lung diseases; pharmaceutical preparations for immunity adjustment; monoclonal antibodies for medical purposes; preparations for the treatment of auto-immune diseases
GS0051Pharmaceutical preparations, namely, immunosuppressants, pharmaceutical preparations for the treatment of COVID-19, and anti-interleukin-6 (il-6) receptor monoclonal antibody for the treatment of disease caused by il-6 production; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for suppressing cytokine; pharmaceutical preparations for the treatment of arteritis; pharmaceutical preparations for the treatment of lung diseases; pharmaceutical preparations for immunity adjustment; monoclonal antibodies for medical purposes; pharmaceutical preparations for the treatment of auto-immune diseases

Trademark Filing History

DescriptionDateEvent Coding
SN ASSIGNED FOR SECT 66A APPL FROM IB2023-04-061 REPR M:
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED2023-04-102 NWOS I:Incoming Correspondence
APPLICATION FILING RECEIPT MAILED2023-04-143 MAFR O:Outgoing Correspondence
ASSIGNED TO EXAMINER2023-12-044 DOCK D:Assigned to Examiner
NON-FINAL ACTION WRITTEN2023-12-055 CNRT R:Renewal
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW2023-12-066 RFCR E:E-Mail
REFUSAL PROCESSED BY MPU2023-12-137 RFRR P:
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB2023-12-138 RFCS P:
REFUSAL PROCESSED BY IB2024-01-029 RFNT P:
TEAS RESPONSE TO OFFICE ACTION RECEIVED2024-01-2310 TROA I:Incoming Correspondence
CORRESPONDENCE RECEIVED IN LAW OFFICE2024-01-2311 CRFA I:Incoming Correspondence
TEAS/EMAIL CORRESPONDENCE ENTERED2024-01-2412 TEME I:Incoming Correspondence
APPROVED FOR PUB - PRINCIPAL REGISTER2024-01-3113 CNSA O:Outgoing Correspondence
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED2024-02-2814 NPUB E:E-Mail
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED2024-02-2815 NONP E:E-Mail
PUBLISHED FOR OPPOSITION2024-03-1916 PUBO A:Allowance for Publication
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED2024-03-1917 NPUB E:E-Mail
REGISTERED-PRINCIPAL REGISTER2024-06-0418 R.PR A:Allowance for Publication
NOTICE OF REGISTRATION CONFIRMATION EMAILED2024-06-0419 NRCC E:E-Mail

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed